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IN HIV-1 infection the ongoing depletion of CD4+
T-lymphocytes is believed, to a large extent, to be
due to apoptosis. Until now quantitative informa-
tion about in vivo apoptosis of lymphocytes in
HIV-patients is scarce because of the very nature
of the apoptotic process. Successful detection of
apoptosis ex vivo requires the recognition of the
initial phase of this process, because at a later
stage the cells may not remain any longer in the
circulation. We measured quantitatively the
amount of early apoptotic peripheral blood lym-
phocytes directly ex vivo in HIV-1 infected pa-
tients using a recently described flow cytometric
assay. With this method we observed in an
unselected heterogenous group of twelve HIV-
infected individuals a median percentage of apop-
totic lymphocytes to be significantly higher than
in ten healthy controls. To the best of our know-
ledge this is the first report of ex vivo observed
increased apoptosis of peripheral blood lympho-
cytes in HIV-infected persons.
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Introduction
HIV-1 infection leads to a gradual depletion of
CD4+ T-lymphocytes. This phenomenon cannot
be explained solely by a direct cytopathic effect
of HIV since the frequency of HIV infection is
as minor as 1 in 100000 cells in early in-
fection. 1’2 Evidence is accumulating that the
CD4+ cell loss is due to apoptosis to a large
extent and that apoptosis of peripheral blood
lymphocytes is a general feature in HIV-infected
persons. This important phenomenon is not
limited to the CD4+ population because in
advanced HIV-1 infection both CD4+ and
CD8+ cells are primed for the cell death
programme, by overexpression of the Fas anti-
gen, a P4hysiological receptor for apoptosis
signalling. Calculations of the turnover rate of
peripheral CD4+ lymphocytes in HIV-1 infected
patients resulted in estimates of 3 107 cells
per day suggesting a high apoptotic rate.5 These
data could not been substantiated by direct
measurements because, until now, assays that
provide quantitative information about apopto-
sis lack specificity or sensitivity, are time con-
suming and usually require the destruction of
cell integrity.
Subjects and Methods
We measured quantitatively apoptosis of peri-
pheral blood lymphocytes ex vivo in twelve
HIV-1 infected individuals and in ten healthy
controls using the APOPTESTTM-FITC protocol
(NeXins Research, the Netherlands), which
numerates early apoptotic cells by probing for
cell surface exposed phosphatidylserine (PS)
with FITC labelled annexin and for plasma
membrane integrity by propidium iodide (PI)
exclusion. This test discriminates between in-
tact cells (FITC-/PI-), early apoptotic (FITC+/
PI-) and necrotic cells (FITC+/PI+) as de-
scribed elsewhere.6’7 Procedures followed were
in accordance with the policies of the Institu-
tional Ethical Review Board of the Hospital
Group.
Results
The results of twelve consecutively measured
peripheral blood samples of patients are given
in Table 1. The amount of early apoptotic cells
is expressed as percentage and absolute count
of FITC-positive and PI-negative lymphocytes
being flow cytometric recognized by their
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Table 1. Amount of apoptotic peripheral blood lymphocytes ex vivo in an unselected
group of 12 HIV infected individuals
Patient Lymphocytes Apoptotic cells CD4+ cells CD8/ cells
(ce s/mm (ce s/mm (%) (ce s/mm (ce s/mm
500 48 (3.2) 300 900
2 400 48 (3.4) 300 000
3 600 88 (5.5) 300 800
4 600 203 (12.7) 300 900
5 3 100 394 (12.7) 500 900
6 200 160 (13.3) 180 000
7 400 64 (15.9) 10 200
8 800 138 (17.2) 20 500
9 700 401 (23.6) 20 400
10 nd 113 (28.2) 10 600
11 700 221 (31.5) 190 400
12 700 42 (34.5) 50 400
Mean 336 177 (16.8) 182 750
nd notdone.
scatter properties. Absolute lymphocyte counts
and CD4/ and CDS+ lymphocyte counts were
measured separately. In healthy controls (n
10) a median of 2.1% (range 0.1-3.2) apoptotic
lymphocytes were found whereas in HIV-in-
fected patients the median was 16.8% (3.2-
34.5; p < 0.01 Wilcoxon’s two-sided rank-sum
test). Eleven out of twelve patients had a CD4+
count of less than 400 cells/mm3 and all pa-
tients had CD8/ cell counts in the normal
range (200-1 100/mm).
Discussion
The pathophysiological significance of apopto-
sis in the development of AIDS is not known:
its inhibition in CD4-+- Jurkat T-cell lines en-
hances virus production and infection in vitro.
8
Reports about correlations between apoptosis
and. prolg0ression to disease show conflicting
results.9’ Until now there is little quantitative
data about the occurrence, duration and fre-
quency of apoptosis in vivo in HIV infection
because of the very nature of the process.
Detection of the earliest phase of apoptosis ex
vivo is of paramount importance for measuring
apoptotic cells before they are destroyed by
phagocytes.
11 Our observation shows for the
first time the presence of a considerable degree
of apoptosis in circulating lymphocytes of HI
infected persons. We observed in an unselected,
heterogenous group of twelve HIV-1 infected
individuals a median percentage of apoptotic
lymphocytes to be significantly higher than in
ten healthy controls. Patients nos 11 and 12
who showed the highest percentage of apopto-
tic lymphocytes were treated for ongoing major
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opportunistic infections (cerebral toxoplasmosis
and pulmonary tuberculosis). Probably this
infection served as an additional immunological
stimulant. In HIV-infected patients this para-
doxically induces apoptosis instead of prolifera-
tion as the result of an inappropriate re-
emergence of the programmed cell death path-
way as described after in vitro stimulation.
12
Our experience shows that the annexin V assay
is a feasible and relatively simple method for ex
vivo detection of early apoptotic lymphocytes.
To the best of our knowledge this is the first
report of ex vivo observed increased apoptosis
of peripheral blood lymphocytes in HIV-infected
persons.
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